PROGRESS PHARMA
The computed 12-month bankruptcy probability of PROGRESS PHARMA is 0.3% (very low). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 13 yrs |
| Board | 6 |
| Locations | 1 |
| Publications | 6 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro | 05-06-2026 | 2026-00144919 |
| 31-12-2024 | micro | 16-05-2025 | 2025-00100013 |
| 31-12-2023 | micro | 27-06-2024 | 2024-00171151 |
| 31-12-2022 | micro | 20-06-2023 | 2023-00139790 |
| 31-12-2021 | micro | 04-07-2022 | 2022-20137663 |
| 31-12-2020 | micro | 28-06-2021 | 2021-25600236 |
| 31-12-2019 | micro | 30-06-2020 | 2020-23800593 |
| 31-12-2018 | micro | 21-06-2019 | 2019-20900043 |
| 31-12-2017 | micro | 25-06-2018 | 2018-23100010 |
| 31-12-2016 | verkort | 23-05-2017 | 2017-13200118 |
-
Fin AccountingLegal entityDirector· perm. rep.: van Dongen Emilius Hubertus Adrianus MariaState Gazette act 26002483 (06-01-2026)Current06-01-2026 → present
-
Salvegen Healthcare B.V.Legal entityManaging director· perm. rep.: Emilius van DongenState Gazette act 24146145 (10-10-2024)Current09-06-2023 → present
-
CONCORDE CONSULTINGLegal entityDirector· perm. rep.: Van Broekhoven Dirk Leo Esther MariaState Gazette act 26002483 (06-01-2026)Current06-04-2020 → present
2 events
- 06-01-2026 Mandate renewed· Director
- 06-04-2020 Appointed· Director
-
Current06-04-2020 → present
2 events
- 06-01-2026 Mandate renewed· Director
- 06-04-2020 Appointed· Director
-
R&S ConsultingLegal entityDirector· perm. rep.: Reyn Dirk Maria JozefState Gazette act 26002483 (06-01-2026)Current06-04-2020 → present
2 events
- 06-01-2026 Mandate renewed· Director
- 06-04-2020 Appointed· Director
-
SIMBIOSIS.LIFELegal entityDirector· perm. rep.: Cools Marina, Marina Lucie LouiseState Gazette act 26002483 (06-01-2026)Current06-04-2020 → present
2 events
- 06-01-2026 Mandate renewed· Director
- 06-04-2020 Appointed· Director
Historic, not recently confirmed (2)
-
EMSA B.N. BOLegal entityManaging director· perm. rep.: Emilius van DongenState Gazette act 16171806 (15-12-2016)Not recently confirmedlast confirmed in an act from 2016
-
R&S Consulting BVBALegal entityDirector· perm. rep.: Dirk ReynState Gazette act 16171806 (15-12-2016)Not recently confirmedlast confirmed in an act from 2016
2 events
- 15-12-2016 Resigned· Managing director
- 15-12-2016 Appointed· Director
Former directors (1)
-
EMSA B.V.Legal entityDirector· perm. rep.: Emilius van DongenState Gazette act 20047363 (06-04-2020)Former23-03-2020 → 09-06-2023
4 events
- 09-06-2023 Resigned· Director
- 06-04-2020 Resigned· Director
- 06-04-2020 Appointed· Director
- 23-03-2020 Appointed· Managing director
| NACE primary | 72109 |
| Legal form | Public limited company(014) |
| Incorporation | 27-06-2013 |
| Status | Active |
| Postal code | 2350 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13046A0176/00K003 | Flanders | 2,539 m² | 1 · 286 m² | 11.6 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-01-2026 Capital decrease of €398,500 to €61,500
- €460.000 → €61.500
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_decrease",
"amount": 40000,
"currency": "EUR",
"after_eur": 460000,
"delta_eur": -40000,
"before_eur": 500000,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-12-19",
"evidence_quote": "Vermindering van het kapitaal met VEERTIGDUIZEND EURO (\u20AC 40.000,00) om het te brengen van VIJFHONDERDDUIZEND EURO (\u20AC 500.000,00) op VIERHONDERD ZESTIGDUIZEND EURO (\u20AC 460.000,00)",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 398500,
"currency": "EUR",
"after_eur": 61500,
"delta_eur": -398500,
"before_eur": 460000,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-12-19",
"evidence_quote": "Beslissing om een deel van de overgedragen verliezen ... aan te zuiveren door een formele kapitaalsvermindering van DRIEHONDERDACHTENNEGENTIGDUIZEND VIJFHONDERD EURO (\u20AC 398.500,00). Hierdoor wordt het kapitaal verminderd van VIERHONDERD ZESTIGDUIZEND EURO (\u20AC 460.000,00) naar EENENZESTIGDUIZEND VIJFHONDERD EURO (\u20AC 61.500,00)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0536.258.560",
"name_full": "PROGRESS PHARMA",
"legal_form": "NV"
}
}10-10-2024 1 director appointed, 1 resigning
- Emilius van Dongen, Gedelegeerd bestuurder
- Emilius van Dongen, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emilius van Dongen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "EMSA B.V.",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-06-09",
"evidence_quote": "Op datum van 9 juni 2023 aanvaardt de algemene vergadering met unanimiteit het ontslag van EMSA B.V., besloten vennootschap naar Nederlands recht,vast vertegenwoordigd door dhr. Emilius van Dongen"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Emilius van Dongen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Salvegen Healthcare B.V.",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-06-09",
"evidence_quote": "Op datum van 9 juni 2023 aanvaardt de algemene vergadering met unanimiteit ... benoemt Salvegen Healthcare B.V., besloten vennootschap naar Nederlands recht, vast vertegenwoordigd door dhr. Emilius van Dongen, als afgevaardigd bestuurder voor een mandaat dat eindigt op 09/06/2029."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0536.258.560",
"name_full": "PROGRESS PHARMA",
"legal_form": "NV"
}
}06-04-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2020-03-23",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0536.258.560",
"name_full": "PROGRESS PHARMA",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "Volmacht wordt verleend aan de besloten vennootschap Innofocus, St-Michielskaai 34, 2000 Antwerpen, BE 0475.217.715, met recht van indeplaatsstelling, om namens en voor rekening van. de vennootschap, naar aanleiding van de bij deze vergadering genomen besluiten, door bemiddeling van een erkend ondernemingsloket naar keuze, alle wettelijke administratieve formaliteiten te laten uitvoeren voor het actualiseren van de in de Kruispuntbank van Ondernemingen geregistreerde identificatiegegevens, alsook bij de diensten van de Belasting over de Toegevoegde Waarde.",
"holder_kbo": "0475.217.715",
"holder_name": "Innofocus",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": [
{
"name": "EMSA B.V.",
"quote": "de voormelde vennootschap EMSA B.V. benoemd wordt tot gedelegeerd bestuurder.",
"excluded_powers": null
}
]
}
}15-12-2016 2 directors appointed, 1 resigning
- Emilius van Dongen, Gedelegeerd bestuurder
- Dirk Reyn, Bestuurder
- Dirk Reyn, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Dirk Reyn",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "R\u0026S Consulting BVBA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Op datum van 12 mei 2016 aanvaardt de algemene vergadering met unanimiteit het ontslag van R\u0026S Consulting BVBA, vast vertegenwoordigd door dhr. Dirk Reyn als afgevaardigd bestuurder"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Emilius van Dongen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "EMSA B.N. BO",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "en benoemt EMSA B.N. BO, vast vertegenwoordigd door dhr. Emilius van Dongen, als afgevaardigd bestuurder voor een mandaat dat eindigt op 9/5/2019."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dirk Reyn",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "R\u0026S Consulting BVBA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "R\u0026S Consulting BVBA, vast vertegenwoordigd door dhr. Dirk Reyn wordt benoemd als voorzitter ter vervanging van EMSA B.N. BO, vast vertegenwoordigd door dhr. Emilius van Dongen."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0536.258.560",
"name_full": "PROGRESS PHARMA",
"legal_form": "NV"
}
}03-04-2015 Registered office moved within Vosselaar
- Oudebaan 34, 2350 Vosselaar → Roekendreef 14, 2350 Vosselaar
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Vosselaar",
"region": null,
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14"
},
"old_address": {
"city": "Vosselaar",
"region": null,
"street": "Oudebaan",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "34"
},
"effective_date": "2015-01-18",
"evidence_quote": "De Raad van Bestuur dd. 18/1/2015 neemt eenparig de beslissing om de maatschappelijke zetel van de: vennootschap te verplaatsen naar Roekendreef 14 te 2350 Vosselaar, Belgi\u00EB."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0536.258.560",
"name_full": "PROGRESS PHARMA",
"legal_form": "NV"
}
}10-07-2013 Incorporation of a new NV
Technical details
{
"kind": "oprichting",
"seat": "2350 Vosselaar, Oudebaan 34",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0885.025.228",
"name": "Horizon Pharmaventures"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": "0885.025.228",
"holder_org_name": "Horizon Pharmaventures",
"contribution_type": "cash",
"amount_paid_in_eur": 71250,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 142500,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Van Broekhoven Dirk Leo Esther Maria",
"niss": null,
"address": "2530 Boechout, Breemlaan 24"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Van Broekhoven Dirk Leo Esther Maria",
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 30000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Ligtvoet Jourik",
"niss": null,
"address": "2250 Olen, Pastoriestraat 3"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 10000,
"holder_person_name": "Ligtvoet Jourik",
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 20000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Kerstens Ren\u00E9 Marinus Adrianus Maria",
"niss": null,
"address": "Hellebaard 8, 5081 RS Hilvarenbeek, Nederland"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 10000,
"holder_person_name": "Kerstens Ren\u00E9 Marinus Adrianus Maria",
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 20000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0806.950.621",
"name": "Pharmaparacelsus"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": "0806.950.621",
"holder_org_name": "Pharmaparacelsus",
"contribution_type": "cash",
"amount_paid_in_eur": 12500,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 25000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0818.008.225",
"name": "Simbiosis.Life"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": "0818.008.225",
"holder_org_name": "Simbiosis.Life",
"contribution_type": "cash",
"amount_paid_in_eur": 10000,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 20000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "PMD Consulting Holding BV"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "PMD Consulting Holding BV",
"contribution_type": "cash",
"amount_paid_in_eur": 12500,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 25000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "van Dongen Emilius Hubertus Adrianus Maria",
"niss": null,
"address": "Utrechtseweg 179, 6862 AJ Oosterbeek, Nederland"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "van Dongen Emilius Hubertus Adrianus Maria",
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 10000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "Rocky Top Pharmaceutical Consulting"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "Rocky Top Pharmaceutical Consulting",
"contribution_type": "cash",
"amount_paid_in_eur": 625,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 1250,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Lammens Luc Marie Antoon Ang\u00E8le",
"niss": null,
"address": "9140 Temse, Schauselhoekstraat 1"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3125,
"holder_person_name": "Lammens Luc Marie Antoon Ang\u00E8le",
"is_subscriber_only": false,
"n_shares_subscribed": null,
"amount_subscribed_eur": 6250,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 600000,
"subject_company": {
"kbo": "0536.258.560",
"name_full": "Progress Pharma",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2013-06-27",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | PROGRESS PHARMA |